Medical World News® Deep Dive: Mehmet Sitki Copur, MD, on the Potential of mRNA Vaccines in Cancer Immunotherapy

Video

Copur spoke with CancerNetwork® about the potential for a new era of cancer treatment and immunotherapy with the recent approval of mRNA vaccines to treat COVID-19.

CancerNetwork® sat down with Mehmet Sitki Copur, MD, Medical Director of Oncology, Medical Oncology/Hematology Mary Lanning Healthcare Morrison Cancer Center and Professor, University of Nebraska Medical Center, to discuss his article in the journal ONCOLOGY®, titled “Messenger RNA Vaccines-Beckoning of a New Era in Cancer Immunotherapy.”

Copur discussed how the approval of recent messenger RNA (mRNA) vaccines by the FDA to combat COVID-19 opens a door for the potential future of cancer immunotherapy and mRNA vaccines.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
coronavirus
Related Content
Subgroup data indicate a positive efficacy trend for TG4001 plus avelumab among patients with cervical cancer.

Cancer Vaccine Combo Does Not Improve PFS in Cervical/Anogenital Tumors

Russ Conroy
October 15th 2024
Article

Subgroup data indicate a positive efficacy trend for TG4001 plus avelumab among patients with cervical cancer.

Cancer vaccines may pair well with other forms of immunotherapy in the treatment of patients with cancer, according to Catherine J. Wu, MD.

Taking a “Cross-Cutting Approach” With Cancer Vaccinations

Catherine J. Wu, MD
August 12th 2024
Podcast

Cancer vaccines may pair well with other forms of immunotherapy in the treatment of patients with cancer, according to Catherine J. Wu, MD.

An updated guideline from ASCO highlights appropriate use of vaccines for patients with cancer receiving treatments such as CAR T-cell therapy or B-cell depleting therapy.

Updated ASCO Guideline Issues Vaccine Recommendations in Cancer Populations

Russ Conroy
March 31st 2024
Article

An updated guideline from ASCO highlights appropriate use of vaccines for patients with cancer receiving treatments such as CAR T-cell therapy or B-cell depleting therapy.

Oncology Peer Review On-The-Go: COVID-19, Cancer, and the Potential of mRNA Vaccines

Oncology Peer Review On-The-Go: COVID-19, Cancer, and the Potential of mRNA Vaccines

Matthew Fowler
March 30th 2021
Podcast

Mehmet Sitki Copur, MD, discussed his article in the Journal ONCOLOGY® focusing on COVID-19, messenger RNA vaccines, and the excitement surrounding its integration into the future of cancer treatment.

Those immunized between the ages of 12 and 13 in England experienced a significant estimated reduction in cervical cancer and grade 3 cervical intraepithelial neoplasia incidence rates compared with unvaccinated women.

Cervical Cancer and Grade 3 Cervical Intraepithelial Neoplasia Incidence Reduced in Young, HPV-Vaccinated Individuals

Matthew Fowler
November 4th 2021
Article

Those immunized between the ages of 12 and 13 in England experienced a significant estimated reduction in cervical cancer and grade 3 cervical intraepithelial neoplasia incidence rates compared with unvaccinated women.

UV1 Cancer Vaccine Receives FDA Fast Track Designation in Melanoma

UV1 Cancer Vaccine Receives FDA Fast Track Designation in Melanoma

Ariana Pelosci
November 3rd 2021
Article

UV1 has received fast track designation from the FDA for the use in unresectable or metastatic melanoma.